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Influenza Pandemic 2009e2010 in Korea?The influenza A/H1N1 pandemic in 2009e2010 had
a huge impact on scientists and public health au-
thorities in the public health sector of Korea before
and after the event. Laboratory scientists traced the
pathogenesis and chronological localization of influ-
enza A/H1N1 [1], and also checked antiviral resis-
tance in Korea [2]. Surveillance data on influenza-like
illness (ILI) were utilized to estimate the number of
influenza patients in Korea [3]. Mathematical mod-
elers evaluated the parameters of the existing pre-
paredness plans in Korea [4].
In this issue, two studies deal with the effectiveness
of vaccination against the H1N1pdm09 virus. One study
was conducted under a military setting to measure its
effectiveness [5]. The H1N1pdm09 vaccine, which was
administered in January 2010, had approximately 50%
effectiveness against the H1N1pdm09 outbreak that
occurred in December 2010. The magnitude of vacci-
nation effectiveness was robust with no substantial dif-
ference, even when multivariate analysis and various ILI
definitions were used.
The magnitude of vaccine effectiveness was lower in
this study than the 70% effectiveness during the
H1N1pdm09 season (2009e2010) in previous studies,
but was similar to the effectiveness during the following
season (2010e2011) in previous studies. Studies that
evaluated the vaccination effectiveness 1 year after a
vaccination program have indicated that the vaccination
effectiveness was not persistent because there were no
statistically significant results [6,7]. However, the cur-
rent study showed that there was still a statistically
significant vaccination effectiveness 1 year after the
vaccination. This was immunologically consistent with
the results of an existing antigenicity study in which the
vaccination effectiveness was persistent 1 year afterThis is an Open Access article distributed under the terms of the C
creativecommons.org/licenses/by-nc/3.0) which permits unrestrict
medium, provided the original work is properly cited.
Copyright ª 2013 Korea Centers for Disease Control and Preventionseasonal influenza vaccination, although the antibody
titer decreased [8].
This study has shown a unique approach to evaluate
the effectiveness of mass vaccination in Korea. This
evaluation would provide a valuable insight for public
health officials and scientists to prepare for the next
possible pandemic in Korea.
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